MedTrace Logo

Effects of Long Term Albumin 20% Administration in Patients With Cirrhosis and Ascites.

NCT00968695 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-06-26

No results posted yet for this study

Summary

Effects of long term albumin administration on the cardiocirculatory and renal function and hepatic hemodynamics in patients with advanced cirrhosis and ascites.

Conditions

  • Cirrhosis
  • Ascites

Interventions

DRUG

Albumin

The pattern of administration of 20% human albumin is 1.5g/kg every week to be infused in 6 hours with a minimum of 90g up and a maximum of 150g in patients weighing less than 60 kg and more than 100 kg, respectively. Treatment duration is 12 weeks, which are 13 administrations of albumin.

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    collaborator OTHER

  • Instituto Grifols, S.A.

    lead INDUSTRY

Principal Investigators

  • Vicente Arroyo, MD · Hospital Clínic of Barcelona

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00968695 on ClinicalTrials.gov